Yield10 Bioscience and BioMar Group have signed an agreement to form a long-term partnership to commercialize a Camelina crop containing enriched levels of EPA and DHA.
Yield10 Bioscience says it has exercised its option to finalize a global, commercial license to advanced omega-3 production technology from UK based Rothamsted Research.